Early stage adenocarcinoma of the jugular abdominal region has a survival rate of 70%~80% in 5 years through timely treatment, depending on the individual’s mentality, treatment effect, and so on. Early stage adenocarcinoma of the jugular abdominal region can prolong the survival period of patients and improve the life treatment through timely treatment, and the survival rate of 5 years is relatively high, which can reach 70%~80%. If the patient has a good mindset or the treatment effect is outstanding, the survival rate will be even higher. However, some patients with early-stage adenocarcinoma of the jugular abdominal region have a bad mentality, and they will have excessive fear and anxiety about the disease, which will lead to poor treatment effect in the later stage, and may indirectly affect the survival rate, therefore, the survival rate within 5 years may be decreased. If early adenocarcinoma of juxta-abdomen is diagnosed, it should be treated in time to prevent the delay of the disease leading to metastasis and spread of cancer cells, but the specific medication should be administered under the guidance of physicians.